DRUG · Unmapped registry intervention
AUY922
Find medicine records ·
Find other trials using this name
Clinical trial
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
NCT01361945
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Metastatic Breast Cancerunresolved
HER-2 Positive Breast Cancerunresolved
ER Positive Breast Cancerunresolved
Interventions
AUY922DRUG
Sponsors & collaborators
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01361945 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.